Erik Kopp Email & Phone Number

Executive Director, Corporate Communications and Investor Relations @ Sironax

View Erik's Email & Phone Number

5 free lookup(s). No credit card required.

If you need more lookups, subscriptions start at $34 USD/month.

Erik Kopp Location

United States

Erik Kopp Work

2025 -now Executive Director, Corporate Communications and Investor Relations @
2021 -2025 Senior Director Corporate Communications @
2020 -2021 Senior Director, Communications @
2013 -2019 Senior Director, Corporate Communications @
2010 -2012 Global Corporate Communications Director @
2009 -2010 U.S. Enterprise and Executive Communications Director @
2007 -2009 Global Corporate Communications Director @ Barr Pharmaceuticals (acquired by Teva)
2001 -2006 Public Relations Manager @

Erik Kopp Education

American University
Master's degree (Journalism and Public Affairs)
Goshen College
Bachelor's degree (Communication)

Erik Kopp Skills

Project Management
Strategic Communications
Microsoft Excel
Corporate Communications
Training
Communications
Writing
Positioning
Keynote Speaker
Global Health
Consulting
Workforce
Capital Management
Confectionery
Suppliers
Position Statements
Channel
Adobe Contribute
Corporate Functions
Audio Conferencing
Vendors
Spokesperson
Sales
Community
Neuroscience
Hypertension
Business Value
Net
Fish
Fortune 500
Consideration
Wood
Briefings
Gartner
European Markets
Finance
Investor Relations
Serving
Reputation Management
Driving
Arthritis
Adoption
Social Responsibility
Internal Communications
Crisis Management
Informative
Product Management
Arc
Organizational Structure
Content Development
Management
Data Transformation
Financial Statements
Public Relations
Marketing Communications
Recycling
Standby
Corporate Actions
Resume
Signage
Therapeutic Areas
Delivering Results
Engaging
Integration
Pollution
CRM
Bylined Articles
Depot
Hiring
Halls
Sensitive Issues
Boston
Friendly
Publications
Hard Drives
Blood
Respiration
Human Resources
Pennsylvania
Execution
Cardiovascular
Change Communications
Bone
Press Releases
Messaging
Brand Awareness
Strategic Initiatives
Healthcare
Rebranding
Publishing
Utilization
Caliber
Nyse
Croatia
Strategy
Active Pharmaceutical Ingredients
Organizational Restructuring
Tsunami
Branding
Agreement
Strategies
Mass
Acquisitions
Information Quality
Oncology
Editing
Policy
Microsoft Publisher
Prescription
Patient
Enterprise Software
Media Events
Surveying
Intranet
CI
Scripting
Robust
Informatics
American
Product Launch
Articles
Pharmaceutical Sales
Communication Training
Crisis
Shares
Corporate Social Responsibility
Stakeholders
Writers
Journalists
High Performance Computing
Newspapers
Campaigns
Written
Partnerships
Medical Marketing
Promoting
Advertising Agency
Tactics
Trident
Biopharmaceuticals
Website Development
Information Technology
Business Partnering
Crisis Communications
Social Media
Verizon
Metabolism
Employee Engagement
Medical Technology
Media Relations
Legislative Relations
Reactive
Communication
Schedules
International Product Launches
Advertising
Rapid Growth
Scientific
Novartis
Safety
Editorial
Consolidating
Operations
Swedish
Case Studies
Visibility
Business Partner
Interactive Advertising
Marketing
Donations
Aligning
Change Management
Emergency Management
Value Propositions
Technical Support
Project
Newsletters
Facilities Management
Engagement
IT Sales
McKesson
Nasdaq
Fourth
Covering
Presentations
Staff Retention
Media
LinkedIn
Country
Websites
Responsibility
Internal Audit
Japanese
Targeted Advertising
Corporate Identity
Meaningful
Regulations
Distribution
International
Growth Strategies
Business Units
New Services
Forestry
Executive Management
Milestone
Employee Surveys
Digital Media
Gold
Electronics
Government
Investments
Transplant
Guidelines
Integrated Marketing
Materials
Global Marketing
Medical Devices
Uk Market
Compliance
Annual Reports
Launches
Proposal Writing
Pharmaceutics
Manufacturing
Highlighting
Interviews
Managed Care
Collateral
Corporate Social Media
Announcements
Journalism
Psychotherapy
IR
Budgets
Public Affairs
Business Strategy
Working Environment
Culture
Inclusion
Risk
Television
Pharmaceutical Industry
Meetings
Supply Chain
Mandates
Retirement
Mergers and Acquisitions
Transform
Recruiting
North American
FDA
Americas
Philanthropy
Analysis
White Papers
Databases
Leadership
Thought Leadership
Internal and External Communications
Storytelling

Erik Kopp Summary

Erik Kopp, based in United States, is currently a Executive Director, Corporate Communications and Investor Relations at Sironax. Erik Kopp brings experience from previous roles at BioXcel Therapeutics, Inc., CVS Health, Parexel and Boston Scientific. Erik Kopp holds a Master's degree in Journalism and Public Affairs @ American University. With a robust skill set that includes Project Management, Strategic Communications, Microsoft Excel, Corporate Communications, Training and more. Erik Kopp has 6 emails and 2 mobile phone numbers on RocketReach.